Theratechnologies Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Theratechnologies Inc. with three other companies in this sector in CANADA : Nuvo Pharmaceuticals Inc (2020 sales of 73.78 million Canadian Dollars [US$58.14 million] of which 53% was Commercial Business), Medexus Pharmaceuticals Inc (74.36 million Canadian Dollars [US$58.60 million] ), and Planet 13 Holdings Inc (94.40 million Canadian Dollars [US$74.39 million] of which 100% was cultivation, production and distribution).

Sales Analysis. During the second fiscal quarter of 2021, sales at Theratechnologies Inc. totalled C$21.88 million. This is a drop of 8.4% from the C$23.89 million in sales at the company during the second quarter in 2020. During the first two fiscal quarters of 2021, sales totalled C$41.55 million, which is 7.0% lower than through the first two quarters of 2020. During the year ended November of 2020, sales at Theratechnologies Inc. were C$88.61 million (US$69.83 million). This is an increase of 5.5% versus 2019, when the company's sales were C$83.99 million. This was the fifth consecutive year of sales increases at Theratechnologies Inc. (and since 2015, sales have increased a total of 195%).